Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
─ William L. Kreienberg Named Chief Corporate Development Executive─ Michael D. Burneal Named Chief Risk and Enterprise Administration Officer WARSAW, N.Y., March 21, 2017 (GLOBE NEWSWIRE) --...
-
Farmingdale, NY, March 21, 2017 (GLOBE NEWSWIRE) -- Cemtrex (Nasdaq: CETX, CETXP, CETXW), a world leading industrial and manufacturing leader, announced today that through its subsidiary, Advanced...
-
LONG BEACH, N.Y. and MIAMI BEACH, Fla., March 21, 2017 (GLOBE NEWSWIRE) -- Net Element, Inc. (NASDAQ:NETE) (“Net Element” or the “Company”), a provider of global mobile payment technology solutions...
-
EAST PALO ALTO, CA--(Marketwired - Mar 21, 2017) - Finjan Holdings, Inc. (NASDAQ: FNJN), a cybersecurity company, and its subsidiary Finjan, Inc. ("Finjan") announced that on March 16 and 17, 2017,...
-
RICHMOND, Calif., March 21, 2017 (GLOBE NEWSWIRE) -- Ekso Bionics Holdings, Inc. (NASDAQ:EKSO), a robotic exoskeleton company, today announced that the EksoGT has been named as a finalist in Fast...
-
FuelCell Energy to commence market activities for Asian market development offering entire portfolio of SureSource™ solutionsPOSCO Energy to support existing South Korean fuel cell installations and...
-
NEWTOWN, Pa., March 21, 2017 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ:ONTX), a Phase 3 clinical stage biopharmaceutical company focused on discovering and developing novel products to...
-
NEW YORK, March 21, 2017 (GLOBE NEWSWIRE) -- MYnd Analytics, Inc. (OTCQB:MYAN), a predictive medicine company which brings objective physical findings to psychiatric treatment in order to reduce...
-
NORCROSS, Ga., March 21, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, announced today that the Company will...
-
SOLANA BEACH, Calif., March 21, 2017 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ:EVOK), a specialty pharmaceutical company focused on treatments for gastrointestinal (GI) diseases, today...